HOME >> MEDICINE >> NEWS
Disease testing for immigrants: Discrimination disguised as public health policy

Policies that deny visas to prospective immigrants on the basis of disease are discriminatory, designed to seize on public fears, and do not protect public health, states an editorial in this week's issue of The Lancet.

Last week, UK opposition-party leader Michael Howard announced that his party would deny visas to prospective immigrants who test positive for tuberculosis (TB). HIV tests would also be mandatory under the Conservative policy, but visas would not necessarily be withheld. This plan, says Howard, is a strategy to minimise the public-health threats posed by immigrants. But the intense debate these proposals have generated-mainly because of their similarity to current government policies-has unfortunately obscured a more important point: that disease must not be a basis for discrimination, writes The Lancet.

In the UK, migration has been blamed for a steady increase in newly diagnosed HIV infections, but absolute numbers remain small. Percentage calculations, such as those cited in Howard's publicity material, exaggerate the relative burden of immigration-related illness. According to the Health Protection Agency's most recent report, the number of newly diagnosed HIV infections thought to have been contracted outside the UK in 2003 number only around 3000.

Reacting to public fears over perceived threats, countries including Canada, USA, Australia, and New Zealand, have adopted stringent policies for compulsory screening of new entrants for TB and HIV. But the only UK public inquiry into the issue came out firmly against the idea, concluding that "there is no evidence to suggest that such a policy would be effective at protecting public health". The All Party Parliamentary Group on AIDS, which set up the inquiry, expressed grave concerns that the government was seeking ways to "exclude vulnerable individuals on the basis of poor health".

The Lancet comments: "Policies that discriminate against visa applican
'"/>

Contact: Udani Samarasekera
pressoffice@lancet.com
44-207-424-4949
Lancet
24-Feb-2005


Page: 1 2

Related medicine news :

1. 2005 Basic Research in Periodontal Disease Award
2. The Larry King Cardiac Foundation presents The Changing Face of Heart Disease on Feb. 2
3. Study finds lemons, lilac among top 10 smells that predict Alzheimers Disease
4. New studies on Ritalin and Alzheimers Disease highlight ACNP Annual Meeting
5. University seeks recruits for Parkinsons Disease study
6. 2004 Research in Periodontal Disease Award to Soskolne
7. Robert Wood Johnson Medical School researcher receives fellowship for work in Canavan Disease
8. Northwestern named Udall Center for Parkinsons Disease Research
9. The Lancet Infectious Diseases (TLID)
10. The Lancet Oncology (TLO) and the Lancet Infectious Diseases (TLID)
11. UCSDs Victor Nizet, M.D., receives Pediatric Infectious Diseases Award

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/19/2019)... ... February 19, 2019 , ... ... stigma in pregnant and postpartum women, a team led by a Worcester Polytechnic ... postpartum often show increased depressive symptoms, greater weight gain during pregnancy, and weight ...
(Date:2/19/2019)... ... February 19, 2019 , ... Landscape Structures Inc., a Delano, Minn.-based commercial ... to be a stunning and fun addition to any play space. Spinning is one ... Curva™ Spinners will provide kids’ brains with valuable equilibrium information. , Whether park and ...
(Date:2/19/2019)... ... February 19, 2019 , ... ... experience to The Oncology Institute of Hope and Innovation. , Dr. Lombardi completed ... cum laude. He received his medical degree from the University of Rochester School ...
(Date:2/19/2019)... ... February 19, 2019 , ... ClearHealth ... to Foley & Lardner LLP, as Recognized Consultants. The CHQI Recognized Consultant Program ... in pursuing CHQI accreditation. , Ms. Wein and Mr. Einhorn are part ...
(Date:2/19/2019)... Fla. (PRWEB) , ... February 18, 2019 , ... ... in the nation to test the PathO3Gen Solutions Footwear Sanitizing Stations to maximize ... Solestice 3/15 TechnologyTM to kill superbugs such as MRSA and C. difficile, which ...
Breaking Medicine News(10 mins):
(Date:2/19/2019)... (PRWEB) , ... February 19, ... ... and infrastructure solutions provider for global service providers, enterprises, and developers, announced ... orchestration platform with the Arvizio MR Studio mixed reality visualization and collaboration ...
(Date:2/19/2019)... ... February 19, 2019 , ... ... for Stage IV metastatic breast cancer (MBC), announces the opening of the 2019 ... Fairchild, “In honor of our 10-year anniversary, we are excited to announce we ...
(Date:2/19/2019)... ... February 19, 2019 , ... ... completed his new book “Live Hard Die Young.” Dr. Oexner was the first ... medicine, therapeutic exercise physiology, and nutritional counseling. Dr. Oexner was a supervisor on ...
Breaking Medicine Technology:
Cached News: